Clinical Trials
임상시험 트래커
국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.
기업
41 results
- 2상모집 중· Liver Diseases, Alcoholic에피모스페르민 알파의 알코올 관련 간질환 대상 위약 대비 안전성 및 유효성 연구
A Study to Investigate the Safety and Efficacy of Efimosfermin Alfa Compared With Placebo in Adult Participants With Alcohol-related Liver Disease (ALD)
리드: GSK
- 2상모집 중· Gastrointestinal Neoplasms이매티닙, 수니티닙, 레고라페닙 및 피미테스피브 후 전이성 및/또는 절제 불가능한 위장관기질종양 환자에서의 벨자티닙 연구
A Study of Velzatinib in Participants With Metastatic and/or Unresectable GIST After Imatinib, Sunitinib, Regorafenib, and Pimitespib
리드: GSK
- 2상모집 중· Amyloidosis새로 진단된 경쇄 아밀로이드증 환자에서 벨란타맙 마포도틴 병용 요법의 효능 및 안전성
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis
리드: GSK
- 2상모집 중· Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma재발/전이성 두경부 편평세포암종에서 반응 및 내성 메커니즘 규명을 위한 다중오믹스 바이오마커 평가
A Comprehensive Multiomic Biomarker Evaluation Across Two Single-arm Cohorts to Elucidate Mechanisms of Response and Resistance in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC)
협력: GSK
- 2상모집 중· Multiple Myeloma재발/불응성 다발성 골수종 환자에서 벨란타맙 마포도틴과 표준 치료 병용의 유효성 및 안전성 평가
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
리드: GSK
- 2상모집 중· Irritable Bowel Syndrome과민성 대장증후군 설사형(IBS-D) 및 혼합형(IBS-M) 성인에서 위약과 비교한 Camlipixant의 복부 증상 조사
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
리드: GSK
- 2상모집 중· Salmonella Infections영아에서 침습성 비장티푸스 살모넬라 질환 및 장티푸스에 대한 GVGH iNTS-TCV 백신의 안전성, 반응원성 및 면역 반응 평가
A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella Disease and Typhoid Fever in Infants
리드: GSK
- 2상모집 중· Respiratory Syncytial Virus (RSV)Immunogenicity of RSVPreF3 Vaccine in Immunocompromised Persons
협력: GSK
- 2상모집 중· BronchiectasisA Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
리드: GSK
- 2상모집 중· Alzheimer's DiseaseOpen-label Extension Study in Participants With Early Alzheimer's Disease
리드: GSK
- 2상모집 중· Myelodysplastic SyndromesA Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome
리드: GSK
- 2상모집 중· Pancreatic Adenocarcinoma MetastaticMaintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy
협력: BMS, GSK
- 2상모집 중· Metabolic Dysfunction-Associated SteatohepatitisA Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
리드: GSK
- 2상모집 중· Primary MyelofibrosisStudy of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
리드: GSK
- 2상모집 중· Pancreas NeoplasmsDOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer
협력: GSK
- 2상모집 중· Endometrial Cancer Stage ISATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr)
협력: GSK
- 2상모집 중· Pancreatic AdenocarcinomaDostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI
협력: GSK
- 2상모집 중· Relapsed CancerIsatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma
협력: GSK, 사노피
- 2상모집 중· Pulmonary TuberculosisPlatform Assessing Regimens and Durations In a Global Multisite Consortium for TB
협력: GSK, 얀센(J&J)
- 2상모집 중· SCLC,Extensive StageNiraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC
협력: GSK
- 2상모집 중· Multiple MyelomaStudy of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma
협력: 암젠, GSK
- 2상모집 중· Penile CarcinomaStudy of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma
협력: GSK
- 2상모집 중· Plasma Cell MyelomaBelantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma
협력: GSK
- 2상모집 중· Systemic SclerosisBelimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis
협력: GSK
- 2상모집 중· CancerThe Drug Rediscovery Protocol (DRUP Trial)
협력: 암젠, 아스트라제네카, BMS, GSK, 일라이 릴리, 머크(MSD), 노바티스, 화이자
- 2상모집 중· Intracranial MeningiomaVismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
협력: GSK, 로슈
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.